Moderna, Inc. revenue breakdown overview

Moderna, Inc. revenue for the last year amounted to 6.85 B USD, the most of which — 6.85 B USD — came from its highest performing source at the moment, Messenger RNA (mRNA) Medicines, the year earlier bringing 19.26 B USD. The greatest contribution to the revenue figure was made by Rest of World — last year it brought Moderna, Inc. 3.60 B USD, and the year before that — 7.30 B USD.